首页|期刊导航|癌症生物学与医学(英文版)|Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment:a prospective study of clinical functional MR-based modeling
Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment:a prospective study of clinical functional MR-based modeling
Wenhua Li Lixin Qiu Qirong Geng Jinjia Chang Xiaoying Zhao Xuedan Sheng Wen Zhang Tong Tong Weijian Guo Huan Zhang Zhe Gong Yue Li Zhiyu Chen Xiaodong Zhu Mingzhu Huang Zhe Zhang Chenchen Wang
癌症生物学与医学(英文版)2025,Vol.22Issue(2):166-176,11.
癌症生物学与医学(英文版)2025,Vol.22Issue(2):166-176,11.DOI:10.20892/j.issn.2095-3941.2024.0389
Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment:a prospective study of clinical functional MR-based modeling
Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment:a prospective study of clinical functional MR-based modeling
摘要
关键词
Colorectal cancer/liver metastases/objective response rate/MRKey words
Colorectal cancer/liver metastases/objective response rate/MR引用本文复制引用
Wenhua Li,Lixin Qiu,Qirong Geng,Jinjia Chang,Xiaoying Zhao,Xuedan Sheng,Wen Zhang,Tong Tong,Weijian Guo,Huan Zhang,Zhe Gong,Yue Li,Zhiyu Chen,Xiaodong Zhu,Mingzhu Huang,Zhe Zhang,Chenchen Wang..Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment:a prospective study of clinical functional MR-based modeling[J].癌症生物学与医学(英文版),2025,22(2):166-176,11.基金项目
This study was supported by the National Natural Science Foundation of China(Grant nos.82271946 and 82202101)and Innovative Achievement Transformation of Shenkang Medical-Enterprise Integration(Grant no.SHDC2023CRD014). (Grant nos.82271946 and 82202101)